BPC-157 (Body Protection Compound 157) is a synthetic peptide derived from a naturally occurring protein in the stomach that dramatically accelerates healing of muscles, tendons, ligaments, and joints while also supporting gut health and reducing systemic inflammation
In conclusion, administration of BPC-157 to alkali-burn wound healing was investigated in the current study
Andrew: -consequences for using these black market, certainly, but dark gray market peptides
LIFT-AD Trial: Phase 2/3 Termination (September 2024) Despite the ACT-AD disappointment, Athira advanced to a larger phase 2/3 trial called LIFT-AD
On the first visit, his vital signs were: blood pressure 149/85 and pulse 80 bpm
The results: 35% reduction in body mass 30% decrease in adipocyte size 40% decrease in adipocyte volume No change in food intake (meaning the weight loss was purely metabolic) Cholesterol levels normalized to those of lean mice This is fundamentally different from appetite suppressants like GLP-1 agonists